Alamar Biosciences, Inc. (ALMR) EBITDA
Alamar Biosciences, Inc. (ALMR) EBITDA
- 2026-06-30: Basis Reported; EBITDA (m); Operating income -$13.53M; Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA (m); Operating income -$12.35M; Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA (m); Operating income -$7.92M; Depreciation and amortization (m).
- 2025-03-31: Basis Reported; EBITDA (m); Operating income -$8.55M; Depreciation and amortization (m).
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | (m) | -$13.53M | (m) | $29.43M | (m) | $3.64M* | -$11.32M* | (m) | $13.82M | $17.43M | -$93.00K |
|---|
| 2026-03-31 | Reported | (m) | -$12.35M | (m) | $26.04M | (m) | $600.00K | -$20.35M | (m) | $13.02M | $13.79M | $464.00K |
|---|
| 2025-06-30 | Reported | (m) | -$7.92M | (m) | $16.16M | (m) | $753.00K* | -$11.88M* | (m) | $8.89M | $7.61M | (m) |
|---|
| 2025-03-31 | Reported | (m) | -$8.55M | (m) | $13.09M | (m) | $554.00K | -$13.07M | (m) | $8.30M | $6.64M | (m) |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|